Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: A monocentric cohort study in China

详细信息    查看全文

• 作者：Zhigang Huang (5)
  Xie Zhang (5)
  Hongna Lu (5)
  Lina Wu (5)
  Danping Wang (7)
  Qiubo Zhang (5)
  Huaxin Ding (6)
  
  5. Department of Gastroenterology ; Lihuili Hospital of Ningbo Medical Center ; 57# Xingning Road ; Ningbo ; 315000 ; China
  7. Ningbo University ; 818# Fenghua Road ; Jiangbei District ; Ningbo ; 315000 ; China
  6. Ningbo Diagnostic Pathology Center ; 2# Guanghua Road ; Ningbo ; 315000 ; China
  
• 关键词：Gastric cancer ; Diagnosis ; Serum trefoil factors ; Pepsinogen
• 刊名：BMC Gastroenterology
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：14
• 期：1
• 全文大小：297 KB
• 参考文献：1. Parkin, DM, Bray, F, Ferlay, J, Pisani, P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: pp. 74-108 CrossRef
  2. Oshima, A, Hirata, N, Ubukata, T, Umeda, K, Fujimoto, L (1986) Evaluation of a mass screening program for stomach cancer with a case鈥揷ontrol study design. Int J Cancer 38: pp. 829-833 CrossRef
  3. Fukao, A, Tsubono, Y, Tsuji, I, Hlsamichi, S, Suqahara, N, Takano, A (1995) The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case鈥揷ontrol study. Int J Cancer 60: pp. 45-48 CrossRef
  4. Abe, Y, Mitsushima, T, Nagatani, K, Lkuma, H, Minamihara, Y (1995) Epidemiological evaluation of the protective eff ect for dying of stomach cancer by screening programme for stomach cancer with applying a method of case鈥揷ontrol study鈥攁 study of an effi cient screening programme for stomach cancer. Nippon Shokakibyo Gakkai Zasshi 92: pp. 836-845
  5. Miki, K, Fujishiro, M, Kodashima, S, Yahaqi, N (2009) Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc 21: pp. 78-81 CrossRef
  6. Hamashima, C, Shibuya, D, Yamazaki, H, Lnoue, K, Fukao, A, Saito, H, Sobue, T (2008) The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 38: pp. 259-267 CrossRef
  7. Miki, K (2011) Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - 鈥淎BC method鈥? Proc Jpn Acad Ser B Phys Biol Sci 87: pp. 405-414 CrossRef
  8. Thim, L, May, FE (2005) Structure of mammalian trefoil factors and functional insights. Cell Mol Life Sci 62: pp. 2956-2973 CrossRef
  9. Taupin, D, Podolsky, DK (2003) Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 4: pp. 721-732 CrossRef
  10. Bossenmeyer-Pouri茅, C, Kannan, R, Ribieras, S, Wendling, C, Stoll, I, Thim, L, Tomasetto, C, Rio, MC (2002) The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J Cell Biol 157: pp. 761-770 CrossRef
  11. Chan, MW, Chan, VY, Leung, WK, Chan, KK, To, KF, Sung, JJ, Chan, FK (2005) Anti-sense trefoil factor family-3 (intestinal trefoil factor) inhibits cell growth and induces chemosensitivity to adriamycin in human gastric cancer cells. Life Sci 76: pp. 2581-2592 CrossRef
  12. Yio, X, Diamond, M, Zhang, JY, Weintein, H, Wang, LH, Werther, L, Itzkowitz, S (2006) Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways. Gastroenterology 130: pp. 1696-1706 CrossRef
  13. Emami, S, Rodrigues, S, Rodrigue, CM, Le Floch, N, Rivat, C, Attoub, S, Bruyneel, E, Gespach, C (2004) Trefoil factor family (TFF) peptides and cancer progression. Peptides 25: pp. 885-898 CrossRef
  14. Yio, X, Zhang, JY, Babyatsky, M, Chen, A, Lin, J, Fan, QX, Werther, JL, Itzkowitz, S (2005) Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells. Clin Exp Metastasis 22: pp. 157-165 CrossRef
  15. Chan, VY, Chan, MW, Leung, WK, Leung, PS, Sung, JJ, Chan, FK (2005) Intestinal trefoil factor promotes invasion in non-tumorigenic Rat-2 fibroblast cell. Regul Pept 127: pp. 87-94 CrossRef
  16. Graness, A, Chwieralski, CE, Reinhold, D, Thim, L, Hoffmann, W (2002) Protein kinase C and ERK activation are required for TFF-peptide-stimulated bronchial epithelial cell migration and tumor necrosis factor-alpha-induced interleukin-6 (IL-6) and IL-8 secretion. J Biol Chem 277: pp. 18440-18446 CrossRef
  17. Wright, NA, Poulsom, R, Stamp, G, Van Noorden, S, Sarraf, C, Elia, G, Ahnen, D, Jeffery, R, Longcroft, J, Pike, C (1993) Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104: pp. 12-20
  18. Podolsky, DK, Lynch-Devaney, K, Stow, JL, Oates, P, Murque, B, Debeaumount, M, Sands, BE, Mahida, YR (1993) Identification of human intestinal trefoil factor, Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268: pp. 6694-6702
  19. Poulsom, R, Hanby, AM, Lalani, EN, Hauser, F, Hoffmann, W, Stamp, GW (1997) Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium. J Pathol 183: pp. 30-38 CrossRef
  20. Devine, DA, High, AS, Owen, PJ, Poulsom, R, Bonass, WA (2000) Trefoil factor expression in normal and diseased human salivary glands. Hum Pathol 31: pp. 509-515 CrossRef
  21. Jagla, W, Wiede, A, Dietzmann, K, Rutkowski, K, Hoffmann, W (2000) Co-localization of TFF3 peptide and oxytocin in the human hypothalamus. FASEB J 14: pp. 1126-1131
  22. Dos Santos, SE, Ulrich, M, Doring, G, Botaenhart, K, Gott, P (2000) Trefoil factor family domain peptides in the human respiratory tract. J Pathol 190: pp. 133-142 CrossRef
  23. Xue, H, L眉, B, Zhang, J, Wu, M, Huang, Q, Wu, Q, Sheng, H, Wu, D, Hu, J, Lai, M (2010) Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 9: pp. 545-555 CrossRef
  24. Qu, Y, Yang, Y, Ma, D, Xiao, W (2012) Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer. Oncol Rep 27: pp. 1277-1283
  25. Aikou, S, Ohmoto, Y, Gunji, T, Matsuhashi, N, Ohtsu, H, Miura, H, Kubota, K, Yamagata, Y, Seto, Y, Nakajima, A, Goldenring, JR, Kaminishi, M, Nomura, S (2011) Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. Gastroenterology 141: pp. 837-845 CrossRef
  26. Bignotti, E, Ravaggi, A, Tassi, RA, Calza, S, Rossi, E, Falchetti, M, Romani, C, Bandiera, E, Odicino, FE, Pecorelli, S, Santin, AD (2008) Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas. Br J Cancer 99: pp. 768-773 CrossRef
  27. Vestergaard, EM, Borre, M, Poulsen, SS, Nex酶, E, T酶rring, N (2006) Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clin Cancer Res 12: pp. 807-812 CrossRef
  28. Dinis-Ribeiro, M, Yamaki, G, Miki, K, Nex酶, E, T酶rring, N (2004) Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 11: pp. 141-147 CrossRef
  29. Shiga, T, Nomoto, K, Nisizawa, M (2000) A study of accuracy of serum pepsinogen method in mass screening and a mass screening using serum pepsinogen. J Gastroenterol Mass Surv 38: pp. 490-495
  30. Yoshihara, M, Sumii, K, Haruma, K, Kiyohira, K, Hattori, N, Tanaka, S, Kajiyama, G, Shigenobu, T (1997) The usefulness of gastric mass screening using serum pepsinogen levels compared with photofl uorography. Hiroshima J Med Sci 46: pp. 81-86
  31. Kitahara, F, Kobayashi, K, Sato, T, Kojima, Y, Araki, T, Fujino, MA (1999) Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 44: pp. 693-697 CrossRef
  32. Mizuno, S, Kobayashi, M, Tomita, S, Onoyama, M, Habu, Y, Inokuchi, H, Watanabe, Y (2009) Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer 12: pp. 158-163 CrossRef
  33. Iijima, K, Abe, Y, Kikuchi, R, Koike, T, Ohara, S, Sipponen, P, Shimosegawa, T (2009) Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 15: pp. 853-859 CrossRef
  34. Yanaoka, K, Oka, M, Yoshimura, N, Mukoubayashi, C, Enomoto, S, Iguchi, M, Magari, H, Utsunomiya, H, Tamai, H, Arii, K, Yamamichi, N, Fujishiro, M, Takeshita, T, Mohara, O, Ichinose, M (2008) Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 123: pp. 917-926 CrossRef
  35. Kaise, M, Miwa, J, Tashiro, J, Ohmoto, Y, Morimoto, S, Kato, M, Urashima, M, Ikegami, M, Tajiri, H (2011) The combination of serum trefoil factor 3 and pepsinogen testing is a valid non-endoscopic biomarker for predicting the presence of gastric cancer: a new marker for gastric cancer risk. J Gastroenterol 46: pp. 736-745 CrossRef
  36. Camorlinga-Ponce, M, Flores-Luna, L, Lazcano-Ponce, E, Herrero, R, Bernal-Sahag煤n, F, Abdo-Francis, JM, Aguirre-Garc铆a, J, Mu帽oz, N, Torres, J (2008) Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Cancer Epidemiol Biomarkers Prev 17: pp. 2498-2504 CrossRef
  37. Muller, W, Borchard, F (1993) pS2 protein in gastric carcinoma and normal gastric mucosa: association with clincopathological parameters and patient survival. J Pathol 171: pp. 263-269 CrossRef
  38. Lefebvre, O, Chenard, MP, Masson, R, Linares, J, Dierich, A, LeMeur, M, Wendling, C, Tomasetto, C, Chambon, P, Rio, MC (1996) Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: pp. 259-262 CrossRef
  39. Im, S, Yoo, C, Jung, JH, Choi, HJ, Yoo, J, Kang, CS (2013) Reduced Expression of TFF1 and Increased Expression of TFF3 in Gastric Cancer: Correlation with Clinicopathological Parameters and Prognosis. Int J Med Sci 10: pp. 133-140 CrossRef
  40. Kirikoshi, H, Katoh, M (2002) Expression of TFF1, TFF2 and TFF3 in gastric cancer. Int J Oncol 21: pp. 655-659
  41. Meng, JR, Tang, HZ, Zhou, KZ, Shen, WH, Guo, HY (2012) TFF3 and surviving expressions associate with a lower survival rate in gastric cancer. Clin Exp Med 13: pp. 297-303 CrossRef
  42. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-230X/14/74/prepub
  
• 刊物主题：Gastroenterology; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-230X

文摘

Background The search for better non-invasive biomarkers for gastric cancer remains ongoing. We investigated the predictive power of serum trefoil factor (TFF) levels as biomarkers for gastric cancer in comparison with the pepsinogen (PG) test. Methods Patients with gastric cancer, chronic atrophic gastritis (CAG) or chronic non-atrophic gastritis (CNAG), and healthy people were recruited. Serum concentrations of TFFs, PG I, and PG II, as well as the presence of antibodies against Helicobacter pylori, were measured by enzyme-linked immunosorbent assays (ELISA). Receiver operating characteristics (ROC) were used to compare the predictive powers of the selected factors. Results The serum concentrations of TFF1, TFF2, and TFF3 in the control groups were significantly lower than those in the gastric cancer group with the exception of TFF2 which was elevated in CAG. The area under the ROC curve for TFF3 was greater than that for the PG I/II ratio (0.81 vs 0.78). TFF3 also had a significantly higher predictive power for distinguishing gastric cancer than the PG test (odds ratio: 10.33 vs 2.57). Moreover, combining the serum TFF3 and PG tests for gastric cancer had better predictive power than either alone. Conclusions Serum TFF3 may be a better predictor of gastric cancer than the PG test, while the combined testing of serum PG and TFF3 could further improve the efficacy of gastric cancer screening.